Event: ANZUP 2023

0:06:51

Genitourinary cancer trials at ANZUP 2023: SUBDUE-1 and ZiPUP

0:01:39

Can the ANZUP surveillance recommendations detect relapse in testicular cancer?

0:04:34

SUBDUE video presentation for EAU 2023 - Dickon Hayne

1:00:24

ACTA Masterclass: Developing a clinical trial network #3 - Funding

0:57:02

GU Cast hosts do battle at ANZUP ASM!!

0:02:24

ANZUP 1301: mitomycin and BCG in non-muscle-invasive bladder cancer

0:16:27

ANZUP in Conversation with Alicia Morgans and Ian Davis #ANZUP2020

0:00:46

CTC HOXB13 RNA in mCRPC: abiraterone/enzalutamide impact

1:56:26

Clinical Investigators Discuss the Current and Future Clinical Care of Patients with Prostate Cancer

0:01:41

PSMAddition: 177Lu-PSMA-617 plus standard of care vs SoC alone in patients with mHSPC

0:01:33

AMBASSADOR: pembrolizumab for locally advanced bladder cancer

0:01:20

Unmet needs in psycho-oncologic support for patients with GU cancer

0:01:48

Does every patients with MIBC require a cystectomy?

0:34:04

Part 1: Presentation

1:10:19

Advanced #ProstateCancer Treatments & Side Effects In 2024 | Elisabeth Heath, MD #PCRI #2024PCRIConf

0:02:34

Supportive care requirements in patients with penile and prostate cancers

0:01:18

CLIMATE: miR-371a-3p as a biomarker in post-orchiectomy testicular cancer

0:01:09

Addressing sexual function issues in patients with genitourinary cancer

0:01:41

What are some remaining challenges in testicular cancer?

0:11:45

Emerging Treatments for BCG Unresponsive Non-muscle Invasive Bladder Cancer

0:38:05

Dana-Farber – Chestnut Hill Virtual Opening Event

0:02:17

Defining future cancer treatments with Professor Lisa Butler | FLOREY 120TH ANNIVERSARY

0:53:40

Live Question & Answer 1

0:27:51

Prostate Cancer Conference Highlights from ASCO 2022